S. 1191 (104th): Consumer Access to Prescription Drugs Act of 1995

Aug 11, 1995 (104th Congress, 1995–1996)
Died (Referred to Committee)
David Pryor
Senator from Arkansas
Read Text »
Last Updated
Aug 11, 1995
5 pages

This bill was introduced on August 11, 1995, in a previous session of Congress, but was not enacted.

Introduced Aug 11, 1995
Referred to Committee Aug 11, 1995
Full Title

A bill to provide for the availability of certain generic human and animal drugs, and for other purposes.


No summaries available.


Senate Health, Education, Labor, and Pensions

The committee chair determines whether a bill will move past the committee stage.

Primary Source

THOMAS.gov (The Library of Congress)

GovTrack gets most information from THOMAS, which is updated generally one day after events occur. Activity since the last update may not be reflected here. Data comes via the congress project.


Get a bill status widget for your website »


Click a format for a citation suggestion:


S. stands for Senate bill.

A bill must be passed by both the House and Senate in identical form and then be signed by the president to become law.

The bill’s title was written by its sponsor.

GovTrack’s Bill Summary

We don’t have a summary available yet.

Library of Congress Summary

The summary below was written by the Congressional Research Service, which is a nonpartisan division of the Library of Congress.

Consumer Access to Prescription Drugs Act of 1995 - Regulates the patent expiration date regarding new drug and new animal drug applications submitted before June 8, 1995 (or submitted after that date but with substantial investment before that date).
Declares that the remedies of certain patent provisions shall not apply to acts that were commenced (or that had substantial investment) before that date and that became infringing by reason of specified provisions of the Uruguay Round Agreements Act. Restricts the circumstances in which equitable remuneration may be awarded.
Sets forth what constitutes:
(1) acts commenced prior to that date; and
(2) substantial investment.
Specifies the application approval and judicial circumstances to which this Act applies.

House Republican Conference Summary

The summary below was written by the House Republican Conference, which is the caucus of Republicans in the House of Representatives.

No summary available.

House Democratic Caucus Summary

The House Democratic Caucus does not provide summaries of bills.

So, yes, we display the House Republican Conference’s summaries when available even if we do not have a Democratic summary available. That’s because we feel it is better to give you as much information as possible, even if we cannot provide every viewpoint.

We’ll be looking for a source of summaries from the other side in the meanwhile.

Use the comment space below for discussion of the merits of S. 1191 (104th) with other GovTrack users.
Your comments are not read by Congressional staff.

comments powered by Disqus